INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2012

Soy isoflavone supplementation reduced blood pressure in hypertensive subjects, but showed no significant effect in normotensive individuals.

A meta-analysis of 11 randomized controlled trials evaluated the effect of dietary soy isoflavones on blood pressure. Overall, soy isoflavones resulted in a mean decrease of 2.5 mm Hg (95% CI: -5.35 to 0.34, P = 0.08) for systolic blood pressure (SBP) and 1.5 mm Hg (95% CI: -3.09 to 0.17, P = 0.08) for diastolic blood pressure (DBP) compared to placebo. In subgroup analyses of hypertensive subjects (5 trials), soy isoflavones significantly reduced SBP by -5.94 mm Hg (95% CI: -10.55 to -1.34, P = 0.01) and DBP by -3.35 mm Hg (95% CI: -6.52 to -0.19, P = 0.04). No significant reduction was found in normotensive subjects (6 trials; SBP: 0.29 mm Hg, P = 0.83; DBP: -0.43 mm Hg, P = 0.50). Authors noted larger trials are needed to confirm the findings.

Study type
Meta-analysis of randomized controlled trials
Who was studied
Participants across 11 randomized controlled trials (including 5 trials of hypertensive subjects and 6 of normotensive subjects)
What was measured
Systolic and diastolic blood pressure

THE PAPER

Effect of soy isoflavones on blood pressure: a meta-analysis of randomized controlled trials.

Liu XX, Li SH, Chen JZ, Sun K, Wang XJ, Wang XG, Hui RT. Nutr Metab Cardiovasc Dis, 2012.

PubMed 21310599 ↗DOI 10.1016/j.numecd.2010.09.006 ↗

Heart & arteriesBlood pressure

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.